The company, which originally expected its shares to be priced between $47 and $55, will ask for $40 a share in a sign of ...

Artificial intelligence chip-making company Cerebras Systems Inc.’s initial public offering has reportedly been delayed ...

Cerebras Systems, a designer of artificial intelligence computers, and a competitor with GPU giant Nvidia, is facing an extended delay for its initial public offering.

The direct-to-consumer genetic testing company filed for Chapter 11 bankruptcy, making one of the world’s largest genetic datasets available for sale. Former CFO turned CEO Elias Apel and VP of ...

CL1 leverages Synthetic Biological Intelligence (SBI), a neural network that integrates lab-grown human neurons with silicon chips. Unlike traditional AI, which relies solely on digital processing ...

The once-thriving primary market, once buzzing with a surge of initial public offerings (IPOs), has entered a quieter phase. Three months into the year, the slowdown in public issues amid a ...

The groundbreaking CL1 biological computer, developed by Cortical Labs, marks a significant milestone in computing technology. Officially unveiled in March 2025, CL1 integrates living human brain ...

EU students: More information on the Call for applicaiton will be available soon. A course delivered entirely in English, with an international approach, teaching the methods and instruments of ...

An Australian startup has unveiled the world’s first commercial biological computer that runs on living human brain cells. Melbourne-based Cortical Labs launched the CL1 at Mobile World Congress ...

The Dividend Safety Scores predict dividend risk over a complete economic cycle. SS determines scores based on an analysis of dividend-related metrics, including payout ratios, debt levels ...

AI just got a reality check. Cortical Labs has officially launched the world’s first commercial biological computer, the CL1, and it’s set to shake up everything from medical science to robotics.

The Washington-based firm is expecting to sell $4 billion to $5 billion in assets this year either through IPOs or the sale of existing investments, roughly in line with the $5 billion of exits ...